These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37715830)

  • 1. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
    Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy.
    Yang Z; Xu J; Li R; Gao Y; He J
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3055-3065. PubMed ID: 31522278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.
    Yang Z; Peng Y; Guo W; Xu J; Li L; Tian H; Li R; Liu L; Tan F; Gao S; He J
    Thorac Cancer; 2021 Jun; 12(11):1743-1751. PubMed ID: 33979899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of B7-H3 and HER2 co-expression and therapeutic value of combination treatment in gastric cancer.
    Shao X; Zhan S; Quan Q; Shen Y; Chen S; Zhang X; Li R; Liu M; Cao L
    Int Immunopharmacol; 2022 Sep; 110():108988. PubMed ID: 35777267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
    Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
    Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value.
    Alhanafy S; Hany H; Nasef K; El-Salkh I; Elhawary A
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2515-2527. PubMed ID: 39068587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration.
    Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
    Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
    Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis.
    Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
    J Pathol Clin Res; 2023 May; 9(3):151-164. PubMed ID: 36598153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.
    Semiz HS; Küçük Ü; Kısa E; Keskinkılıç M; Süyün DE; Arayıcı ME; Atağ E; Karaoglu A
    Prostate; 2022 Dec; 82(16):1564-1571. PubMed ID: 36031743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
    Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):739-747. PubMed ID: 33392661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.
    Zhang K; Xu Y; Chang X; Xu C; Xue W; Ding D; Nie M; Cai H; Xu J; Zhan L; Han J; Cai T; Ju D; Feng L; Zhang X; Yin K
    Cancer Immunol Immunother; 2024 Mar; 73(4):75. PubMed ID: 38532108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments.
    Benesova I; Capkova L; Ozaniak A; Pacas P; Kopeckova K; Galova D; Lischke R; Buchler T; Ozaniak Strizova Z
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):134. PubMed ID: 38493445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.
    Wang JH; Huang ST; Zhang L; Liu ZG; Liang RX; Jiang SW; Jiang YN; Yu XJ; Jiang YC; Li XZ; Zhang PF; Wen ZS; Zheng M
    Cancer Med; 2019 Mar; 8(3):1315-1325. PubMed ID: 30741466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in β-catenin activated melanomas.
    Hsu M; Martin TC; Vyas NS; Desman G; Mendelson K; Horst B; Parsons RE; Celebi JT
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):407-415. PubMed ID: 37086018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis.
    Zhao Q; Cai Q; Yu S; Ji J; Zhu Z; Yan C; Zhang J
    Front Cell Dev Biol; 2021; 9():745120. PubMed ID: 34805154
    [No Abstract]   [Full Text] [Related]  

  • 20. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/Nrf2 pathway.
    Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
    Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.